Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

Jianmin Li, MS

Gilead Sciences, Inc., Foster City, CA, USA

Disclosure(s): Gilead Sciences, Inc.: Employee

Poster(s):

(P-1248) Phase 2 Pharmacokinetics and Anti-Drug Antibody Results of the Investigational Twice-Yearly HIV-1 Treatment Regimen Lenacapavir, Teropavimab, and Zinlirvimab

Tuesday, October 21, 2025
12:15 PM - 1:30 PM US ET